11/18/2022
After a few years paralyzed by the COVID pandemic, once again Rekom Biotech attended the Leading International Trade Fair Medica 2022 in Düsseldorf, Germany, from 14th to 17th November, 2022. Dr. Ana Camacho (CEO & CSO - Ph.D.) and Rosa Mª de Molina (Marketing & IT Manager) had the opportunity to meet our customers and introduce them to our new products and our speciality, chimeras, self-designed proteins composed of multiple epitopes, which have improved their antigenic properties, such as sensitivity and specificity.
(...)
8/2/2022
Rekom Biotech is delighted to announce that we have just started a new distribution partnership with Afirmus Biosource. From now on, our customers from Singapore and Indonesia will be able to purchase our IVD raw materials with the assistance of our new partner.
(...)
7/27/2022
Rekom Biotech is pleased to announce that we have just started a new distribution partnership with Filgen Inc. From now on, our Japanese customers will be able to purchase our IVD raw materials through our new partner.
(...)
6/1/2022
We keep growing! Rekom Biotech is pleased to announce that we have just started a new distribution partnership with MoreBio Co., Ltd. From now on, MoreBio will be the responsible company supervising the distribution of our IVD reagents in the Republic of Korea.
(...)
10/14/2021
The Andalusian Agency for Innovation and Development IDEA, of the Junta de Andalucía, has resolved a grant of subsidies, under a competitive competition regime, to industrial research projects and experimental development projects in Andalusia, 80% co-financed by the European Union through the European Regional Development Fund, FEDER.
(...)
